126 related articles for article (PubMed ID: 33465882)
1. Delivery of Flightless I siRNA from Porous Silicon Nanoparticles Improves Wound Healing in Mice.
Turner CT; Hasanzadeh Kafshgari M; Melville E; Delalat B; Harding F; Mäkilä E; Salonen JJ; Cowin AJ; Voelcker NH
ACS Biomater Sci Eng; 2016 Dec; 2(12):2339-2346. PubMed ID: 33465882
[TBL] [Abstract][Full Text] [Related]
2. Delivery of Flightless I Neutralizing Antibody from Porous Silicon Nanoparticles Improves Wound Healing in Diabetic Mice.
Turner CT; McInnes SJ; Melville E; Cowin AJ; Voelcker NH
Adv Healthc Mater; 2017 Jan; 6(2):. PubMed ID: 27869355
[TBL] [Abstract][Full Text] [Related]
3. Cytoskeletal protein Flightless (Flii) is elevated in chronic and acute human wounds and wound fluid: neutralizing its activity in chronic but not acute wound fluid improves cellular proliferation.
Ruzehaji N; Grose R; Krumbiegel D; Zola H; Dasari P; Wallace H; Stacey M; Fitridge R; Cowin AJ
Eur J Dermatol; 2012; 22(6):740-50. PubMed ID: 23178274
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of Flightless I, a gelsolin family member and developmental regulator, in early-gestation fetal wounds improves healing.
Lin CH; Waters JM; Powell BC; Arkell RM; Cowin AJ
Mamm Genome; 2011 Jun; 22(5-6):341-52. PubMed ID: 21400204
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast-specific upregulation of Flightless I impairs wound healing.
Turner CT; Waters JM; Jackson JE; Arkell RM; Cowin AJ
Exp Dermatol; 2015 Sep; 24(9):692-7. PubMed ID: 25959103
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of flightless I improves wound healing and enhances angiogenesis in a murine model of type 1 diabetes.
Ruzehaji N; Kopecki Z; Melville E; Appleby SL; Bonder CS; Arkell RM; Fitridge R; Cowin AJ
Diabetologia; 2014 Feb; 57(2):402-12. PubMed ID: 24292564
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of Flightless I, an actin-remodelling protein, improves burn injury repair via modulation of transforming growth factor (TGF)-beta1 and TGF-beta3.
Adams DH; Ruzehaji N; Strudwick XL; Greenwood JE; Campbell HD; Arkell R; Cowin AJ
Br J Dermatol; 2009 Aug; 161(2):326-36. PubMed ID: 19519830
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of Flightless I Increases Human Pericyte Proliferation, Migration and Angiogenic Functions and Improves Healing in Murine Diabetic Wounds.
Thomas HM; Ahangar P; Hofma BR; Strudwick XL; Fitridge R; Mills SJ; Cowin AJ
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32764293
[TBL] [Abstract][Full Text] [Related]
9. Gender specific effects on the actin-remodelling protein Flightless I and TGF-beta1 contribute to impaired wound healing in aged skin.
Adams DH; Strudwick XL; Kopecki Z; Hooper-Jones JA; Matthaei KI; Campbell HD; Powell BC; Cowin AJ
Int J Biochem Cell Biol; 2008; 40(8):1555-69. PubMed ID: 18191609
[TBL] [Abstract][Full Text] [Related]
10. Cancer-targeting siRNA delivery from porous silicon nanoparticles.
Wan Y; Apostolou S; Dronov R; Kuss B; Voelcker NH
Nanomedicine (Lond); 2014 Oct; 9(15):2309-21. PubMed ID: 24593001
[TBL] [Abstract][Full Text] [Related]
11. Flightless I deficiency enhances wound repair by increasing cell migration and proliferation.
Cowin AJ; Adams DH; Strudwick XL; Chan H; Hooper JA; Sander GR; Rayner TE; Matthaei KI; Powell BC; Campbell HD
J Pathol; 2007 Apr; 211(5):572-581. PubMed ID: 17326236
[TBL] [Abstract][Full Text] [Related]
12. The influence of Flightless I on Toll-like-receptor-mediated inflammation in a murine model of diabetic wound healing.
Ruzehaji N; Mills SJ; Melville E; Arkell R; Fitridge R; Cowin AJ
Biomed Res Int; 2013; 2013():389792. PubMed ID: 23555084
[TBL] [Abstract][Full Text] [Related]
13. Small interfering RNA delivery by polyethylenimine-functionalised porous silicon nanoparticles.
Hasanzadeh Kafshgari M; Alnakhli M; Delalat B; Apostolou S; Harding FJ; Mäkilä E; Salonen JJ; Kuss BJ; Voelcker NH
Biomater Sci; 2015 Dec; 3(12):1555-65. PubMed ID: 26343506
[TBL] [Abstract][Full Text] [Related]
14. Nanobody-displaying porous silicon nanoparticles for the co-delivery of siRNA and doxorubicin.
Tieu T; Wojnilowicz M; Huda P; Thurecht KJ; Thissen H; Voelcker NH; Cifuentes-Rius A
Biomater Sci; 2021 Jan; 9(1):133-147. PubMed ID: 33135714
[TBL] [Abstract][Full Text] [Related]
15. Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma.
Tong WY; Alnakhli M; Bhardwaj R; Apostolou S; Sinha S; Fraser C; Kuchel T; Kuss B; Voelcker NH
J Nanobiotechnology; 2018 Apr; 16(1):38. PubMed ID: 29653579
[TBL] [Abstract][Full Text] [Related]
16. Flightless I regulates hemidesmosome formation and integrin-mediated cellular adhesion and migration during wound repair.
Kopecki Z; Arkell R; Powell BC; Cowin AJ
J Invest Dermatol; 2009 Aug; 129(8):2031-45. PubMed ID: 19212345
[TBL] [Abstract][Full Text] [Related]
17. In vivo delivery of functional Flightless I siRNA using layer-by-layer polymer surface modification.
Martens PJ; Ly M; Adams DH; Penzkover KR; Strudwick X; Cowin AJ; Poole-Warren LA
J Biomater Appl; 2015 Sep; 30(3):257-68. PubMed ID: 25838352
[TBL] [Abstract][Full Text] [Related]
18. Development of Topical Delivery Systems for Flightless Neutralizing Antibody.
Haidari H; Zhang Q; Melville E; Kopecki Z; Song Y; Cowin AJ; Garg S
J Pharm Sci; 2017 Jul; 106(7):1795-1804. PubMed ID: 28336300
[TBL] [Abstract][Full Text] [Related]
19. Effect of Flightless I Expression on Epidermal Stem Cell Niche During Wound Repair.
Yang GN; Strudwick XL; Bonder C; Kopecki Z; Cowin AJ
Adv Wound Care (New Rochelle); 2020 Apr; 9(4):161-173. PubMed ID: 32117580
[No Abstract] [Full Text] [Related]
20. Flightless I over-expression impairs skin barrier development, function and recovery following skin blistering.
Kopecki Z; Yang GN; Arkell RM; Jackson JE; Melville E; Iwata H; Ludwig RJ; Zillikens D; Murrell DF; Cowin AJ
J Pathol; 2014 Apr; 232(5):541-52. PubMed ID: 24375017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
